Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
11
self-reported band not used
Founded
Not recorded
Legal entities
1
ACRA
Office countries
3
4 addresses
Funding rounds
None on record
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
IX BIOPHARMA LTD.Entity record →
UEN200405621W
Legal entities
Show as table · iX Biopharma: 1 registry entity
| IX BIOPHARMA LTD. | UEN 200405621W |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
iX Biopharma is a listed, specialty pharmaceutical and nutraceutical company focusing on the development and commercialisation of therapies for diseases of the central nervous system using novel, patent-protected formulations for sublingual delivery.
iX Biopharma’s pipeline of products under development includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management. iX Biopharma’s drugs for the treatment of erectile dysfunction, Wafesil, a sublingual sildenafil wafer, and Silcap, have been registered in Australia. iX Biopharma has developed Xativa, the world’s first freeze-dried sublingual medicinal cannabis wafer.
The Group’s nutraceuticals division, Entity Health Limited, is engaged in the development and commercialisation of nutraceutical products.
Subsidiaries:
iX Syrinx ( https://www.ixsyrinx.com )
Entity health ( https://www.entity-health.com )
Specialties
All 4 specialties
- Patented Sublingual Drug Delivery Technology
- Novel Drug Delivery Systems
- Pain Management
- Therapies for diseases of the central nervous system
Locations
3
Countries with an office address4 addresses on record
Country footprint
Show as table · Offices in 3 countries
| Countries | 3 |
|---|---|
| Primary country | SG |
All codes: SG AU CN
Addresses
- SG1 Kim Seng Promenade; 14-01; Singapore, Singapore 237994Primary
- AU110 Merridale Drive; Melbourne, Victoria 3136
- AU24 Augusta Street; Willetton, Western Australia 6155
- CN135 Yanping Road, Jing'an District; Room 227; Shanghai, 200042
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under iX Biopharma?
One Singapore entity on ACRA: IX BIOPHARMA LTD. (UEN 200405621W), high confidence.
How many people work at iX Biopharma?
11 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does iX Biopharma have offices?
4 addresses on record.
Has iX Biopharma raised funding?
None linked to this brand.
What does iX Biopharma list as its specialties?
Four tags on the brand's own list, among them pain management.
Which companies are listed alongside iX Biopharma?
12 profiles list iX Biopharma as a peer — 88th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Haldane Pharmaceuticals Pte Ltd and Blackletter LLC list it back.